Medicare Enrolled
Dr. Anjana Myneni, M.D.
Endocrinology · Bloomfield Hills, MI
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Myneni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Myneni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Myneni
Dr. Anjana Myneni is an endocrinology specialist in Bloomfield Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Myneni performed 1,068 Medicare services across 495 unique beneficiaries.
Between the years covered by Open Payments, Dr. Myneni received a total of $13,160 from 67 pharmaceutical and/or device companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Myneni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in MI
$13,160 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,068
Medicare services
Top 33% in MI for endocrinology
495
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~56 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
345 | $94 | $184 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
280 | $10 | $25 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
164 | $4 | $20 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
136 | $27 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $122 | $236 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
29 | $6 | $10 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
29 | $5 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $127 | $274 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $64 | $153 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
14 | $115 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,160
Total received (2018-2024)
Avg $1,880/year across 7 years
Top 20% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
652
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,160 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,458
2023
$2,641
2022
$2,151
2021
$2,268
2020
$1,027
2019
$1,189
2018
$1,425
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$379
Lilly USA, LLC
$288
CeQur Corporation
$201
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
SANOFI-AVENTIS U.S. LLC
$156
Corcept Therapeutics
$148
Bayer Healthcare Pharmaceuticals Inc.
$118
ABBVIE INC.
$98
Xeris Pharmaceuticals, Inc.
$88
Insulet Corporation
$82
Medtronic, Inc.
$76
Mannkind Corporation
$74
Ascensia Diabetes Care Us Inc.
$69
Amneal Pharmaceuticals LLC
$54
Neurocrine Biosciences, Inc.
$49
Alvogen Inc
$47
Ultragenyx Pharmaceutical Inc.
$44
Amgen Inc.
$44
Chiesi USA, Inc.
$35
Dexcom, Inc.
$34
Abbott Laboratories
$34
Amphastar Pharmaceuticals, Inc.
$33
Alexion Pharmaceuticals, Inc.
$26
RECORDATI_RARE_DISEASES_INC.
$23
Tandem Diabetes Care, Inc.
$22
Esperion Therapeutics, Inc.
$17
IBSA Pharma Inc.
$17
Radius Health, Inc.
$16
Tolmar, Inc.
$16
BETA BIONICS, INC.
$12
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,853
Lilly USA, LLC
$1,455
SANOFI-AVENTIS U.S. LLC
$658
Medtronic, Inc.
$575
Corcept Therapeutics
$452
Dexcom, Inc.
$420
AstraZeneca Pharmaceuticals LP
$396
Senseonics, Incorporated
$387
Amgen Inc.
$376
Xeris Pharmaceuticals, Inc.
$375
Boehringer Ingelheim Pharmaceuticals, Inc.
$322
Abbott Laboratories
$308
CeQur Corporation
$307
Becton, Dickinson and Company
$297
Bayer Healthcare Pharmaceuticals Inc.
$297
Mannkind Corporation
$282
Medtronic MiniMed, Inc.
$265
Radius Health, Inc.
$206
DEXCOM, INC.
$183
ABBVIE INC.
$181
Amneal Pharmaceuticals LLC
$179
Ipsen Biopharmaceuticals, Inc
$178
LifeScan, Inc.
$175
Nevro Corp.
$173
MannKind Corporation
$167
Insulet Corporation
$157
Janssen Pharmaceuticals, Inc
$141
RECORDATI_RARE_DISEASES_INC.
$140
Clarus Therapeutics Inc.
$137
Bayer HealthCare Pharmaceuticals Inc.
$133
Ascendis Pharma Inc
$129
Ultragenyx Pharmaceutical Inc.
$122
Amarin Pharma Inc.
$119
Valeritas, Inc.
$116
LIFESCAN, INC.
$108
Alvogen Inc
$105
Alexion Pharmaceuticals, Inc.
$98
Shire North American Group Inc
$77
Amryt Pharma Holdings Ltd
$73
Embecta Corp.
$72
Ascensia Diabetes Care Us Inc.
$69
Merck Sharp & Dohme Corporation
$68
Zealand Pharma US, Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$62
VIVUS, Inc.
$59
Averitas Pharma Inc.
$55
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
PFIZER INC.
$51
Neurocrine Biosciences, Inc.
$49
AbbVie Inc.
$46
Companion Medical, Inc.
$43
VIVUS LLC
$36
Chiesi USA, Inc.
$35
Horizon Therapeutics plc
$34
Amphastar Pharmaceuticals, Inc.
$33
GRT US Holding, Inc.
$28
Aegerion Pharmaceuticals, Inc.
$26
Tandem Diabetes Care, Inc.
$22
EUSA Pharma (US) LLC
$18
Esperion Therapeutics, Inc.
$17
IBSA Pharma Inc.
$17
Tolmar, Inc.
$16
Eisai Inc.
$15
Antares Pharma, Inc.
$14
Alfasigma USA, Inc.
$13
EISAI INC.
$13
BETA BIONICS, INC.
$12
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CRENESSITY · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · Guardian Sensor 3 · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · QSYMIA · QUTENZA · Qsymia · Qutenza · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Sylvant · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
81
Per 100K population
6.4
County median income
$95,296
Nearest hospital
TRINITY HEALTH OAKLAND HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Myneni is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Myneni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Myneni performed 345 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Myneni receive payments from pharmaceutical companies?
Yes. Dr. Myneni received a total of $13,160 from 67 companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Myneni's costs compare to other endocrinologists in Bloomfield Hills?
Dr. Myneni's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Myneni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Bloomfield Hills
Browse endocrinologists in Bloomfield Hills ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology